A pH-sensitive fusogenic peptide facilitates endosomal escape and greatly enhances the gene silencing of siRNA-containing nanoparticles in vitro and in vivo

被引:205
作者
Hatakeyama, Hiroto [1 ,3 ]
Ito, Erika [1 ,3 ]
Akita, Hidetaka [1 ,3 ]
Oishi, Motoi [2 ,3 ]
Nagasaki, Yukio [2 ,3 ]
Futaki, Shiroh [4 ]
Harashima, Hideyoshi [1 ,3 ]
机构
[1] Hokkaido Univ, Fac Pharmaceut Sci, Kita Ku, Sapporo, Hokkaido 0600812, Japan
[2] Univ Tsukuba, Tsukuba Res Ctr Interdisciplinary Mat Sci TIMS, Tsukuba, Ibaraki 3058573, Japan
[3] Japan Sci & Technol Agcy JST, CREST, Tokyo, Japan
[4] Kyoto Univ, Inst Chem Res, Kyoto 6110011, Japan
基金
日本学术振兴会;
关键词
Multifunctional envelope-type nano device (MEND); siRNA delivery; Intracellular trafficking; PPD; GALA; NANO DEVICE; INTRACELLULAR TRAFFICKING; TRIGGERED RELEASE; SYSTEMIC DELIVERY; LIPOSOMES; TUMOR; POLYPLEXES; PEGYLATION; DNA;
D O I
10.1016/j.jconrel.2009.06.008
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Previously, we developed a multifunctional envelope-type nano device (MEND) for efficient delivery of both pDNA and siRNA. Modification of a MEND with polyuethylene glycol, i.e., PEGylation, is a potential strategy for in vivo delivery of MENDs to tumor tissue. However, PEGylation also inhibits both uptake and endosomal escape of MENDs. To overcome these limitations, we developed a PEG-peptide-DOPE (PPD) that can be cleaved in a matrix metalloproteinase (MMP)-rich environment. In this study, to further improve the silencing activity of encapsulated siRNA, we modified the PPD-MEND with a pH-sensitive fusogenic GALA peptide (GALA/PPD-MEND). First, we determined the GALA and PPD content that would optimize the synergistic functions of GALA and PPD. The most efficient gene silencing activity was achieved when GALA and either conventional PEG-lipid or PPD were used to modify the MEND at a molar ratio of 1:1. In this case, the silencing activity was comparable to that achieved when using a MEND that had not been modified with PEG (unmodified MEND). Furthermore, in vivo topical administration revealed that optimized PPD/GALA-MENDa resulted in more efficient gene silencing compared with unmodified MENDs. Collectively, data demonstrate that introduction of both of a pH-sensitive fusogenic GALA peptide and PPD into the MEND facilitates nanopartide endosomal escape, thereby enhancing the efficiency of siRNA delivery and gene silencing. (C) 2009 Elsevier B.V. All rights reserved.
引用
收藏
页码:127 / 132
页数:6
相关论文
共 29 条
[1]  
CHOI JS, 2003, BIOPHYS J, V84, P1784
[2]   Interfering with disease: a progress report on siRNA-based therapeutics [J].
de Fougerolles, Antonin ;
Vornlocher, Hans-Peter ;
Maraganore, John ;
Lieberman, Judy .
NATURE REVIEWS DRUG DISCOVERY, 2007, 6 (06) :443-453
[3]   Protein transduction domain of HIV-1 Tat protein promotes efficient delivery of DNA into mammalian cells [J].
Eguchi, A ;
Akuta, T ;
Okuyama, H ;
Senda, T ;
Yokoi, H ;
Inokuchi, H ;
Fujita, S ;
Hayakawa, T ;
Takeda, K ;
Hasegawa, M ;
Nakanishi, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (28) :26204-26210
[4]   Stearylated arginine-rich peptides: A new class of transfection systems [J].
Futaki, S ;
Ohashi, W ;
Suzuki, T ;
Niwa, M ;
Tanaka, S ;
Ueda, K ;
Harashima, H ;
Sugiura, Y .
BIOCONJUGATE CHEMISTRY, 2001, 12 (06) :1005-1011
[5]   Embodying a stable alpha-helical protein structure through efficient chemical ligation via thioether formation [J].
Futaki, S ;
Ishikawa, T ;
Niwa, M ;
Kitagawa, K ;
Yagami, T .
BIOORGANIC & MEDICINAL CHEMISTRY, 1997, 5 (09) :1883-1891
[6]   Steric stabilization of fusogenic liposomes by a low-pH sensitive PEG-diortho ester-lipid conjugate [J].
Guo, X ;
Szoka, FC .
BIOCONJUGATE CHEMISTRY, 2001, 12 (02) :291-300
[7]   Roles of lipid polymorphism in intracellular delivery [J].
Hafez, IM ;
Cullis, PR .
ADVANCED DRUG DELIVERY REVIEWS, 2001, 47 (2-3) :139-148
[8]   Development of a novel systemic gene delivery system for cancer therapy with a tumor-specific cleavable PEG-lipid [J].
Hatakeyama, H. ;
Akita, H. ;
Kogure, K. ;
Oishi, M. ;
Nagasaki, Y. ;
Kihira, Y. ;
Ueno, M. ;
Kobayashi, H. ;
Kikuchi, H. ;
Harashima, H. .
GENE THERAPY, 2007, 14 (01) :68-77
[9]   Targeted delivery and triggered release of liposomal doxorubicin enhances cytotoxicity against human B lymphoma cells [J].
Ishida, T ;
Kirchmeier, MJ ;
Moase, EH ;
Zalipsky, S ;
Allen, TM .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2001, 1515 (02) :144-158
[10]   Transferrin-modified liposomes equipped with a pH-sensitive fusogenic peptide: An artificial viral-like delivery system [J].
Kakudo, T ;
Chaki, S ;
Futaki, S ;
Nakase, I ;
Akaji, K ;
Kawakami, T ;
Maruyama, K ;
Kamiya, H ;
Harashima, H .
BIOCHEMISTRY, 2004, 43 (19) :5618-5628